← 治験一覧に戻る
急性虚血性脳卒中患者におけるONO-2506の研究
基本情報
- NCT ID
- NCT00229177
- ステータス
- 完了
- 試験のフェーズ
- 第2/第3相
- 試験タイプ
- 介入
- 目標被験者数
- 757
- 治験依頼者名
- Ono Pharmaceutical Co. Ltd
概要
The purpose of this study is to determine the efficacy and safety of ONO-2506 compared to placebo in patients with acute ischemic stroke.
対象疾患
Stroke
介入
ONO-2506(DRUG)
ONO-2506(DRUG)
ONO-2506(DRUG)
依頼者（Sponsor）
小野薬品工業株式会社(INDUSTRY)
実施施設 (17)
Tohoku Region Facility
Tohuku, Japan
Chugoku Region Facility
Chugoku, Japan
Chubu Region Facility
Chūbu, Japan
Chubu Region Facility
Chūbu, Japan
Hokuriku Region Facility
Hokuriku, Japan
Kinki Region Facility
Kinki, Japan
Kanto Region Facility
Kanto, Japan
Hokuriku Region Facility
Hokuriku, Japan
Shikoku Region Facility
Shikoku, Japan
Kyushu Region Facility
Kyushu, Japan
Kanto Region Facility
Kanto, Japan
Kinki Region Facility
Kinki, Japan
Shikoku Region Facility
Shikoku, Japan
Kyushu Region Facility
Kyushu, Japan
Chugoku Region Facility
Chugoku, Japan
北海道大学病院
Hokkaido, Japan
Tohoku Region Facility
Tohuku, Japan